 - Patients must have had no prior systemic therapy for advanced RCC. Prior systemic therapy is defined as any treatment with a chemotherapy agent or regimen, an immunotherapy agent or regimen or an investigational treatment agent or regimen against the renal cell carcinoma. Megestrol acetate or medroxyprogesterone will constitute as a prior systemic therapy 